Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 06-2023 | 03-2023 | |
Operating Expenses | 7,449 | 5,989 | 0 | 0 | 4,594 |
Operating Income | -7,449 | -5,989 | N/A | N/A | -4,594 |
Interest Expense | 51 | 0 | 0 | 0 | 0 |
Other Income | -58 | 423 | 0 | 0 | 5,595 |
Pre-tax Income | -7,558 | -5,566 | 0 | 0 | 1,001 |
Net Income Continuous | -7,558 | -5,566 | N/A | N/A | 1,001 |
Net Income | $-7,558 | $-5,566 | $N/A | $N/A | $1,001 |
EPS Basic Total Ops | -0.80 | -0.83 | N/A | N/A | 0.27 |
EPS Basic Continuous Ops | -0.80 | -0.83 | N/A | N/A | 0.27 |
EPS Diluted Total Ops | -0.80 | -0.83 | N/A | N/A | 0.27 |
EPS Diluted Continuous Ops | -0.80 | -0.83 | N/A | N/A | 0.27 |
EBITDA(a) | $-7,449 | $-5,976 | $N/A | $N/A | $-4,593 |